GAM Holding’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $2.18M | Sell |
22,849
-3,935
| -15% | -$386K | 0.14% | 147 |
|
|
2025
Q3 | $2.61M | Buy |
26,784
+2,951
| +12% | +$306K | 0.16% | 128 |
|
|
2025
Q2 | $2.56M | Sell |
23,833
-3,943
| -14% | -$399K | 0.18% | 121 |
|
|
2025
Q1 | $2.8M | Buy |
27,776
+6,747
| +32% | +$679K | 0.22% | 103 |
|
|
2024
Q4 | $1.88M | Sell |
21,029
-1,631
| -7% | -$144K | 0.14% | 112 |
|
|
2024
Q3 | $1.9M | Sell |
22,660
-62
| -0.3% | -$4.89K | 0.15% | 114 |
|
|
2024
Q2 | $1.75M | Sell |
22,722
-60
| -0.3% | -$4.39K | 0.13% | 123 |
|
|
2024
Q1 | $1.56M | Sell |
22,782
-1,537
| -6% | -$98.8K | 0.11% | 131 |
|
|
2023
Q4 | $1.41M | Sell |
24,319
-11,479
| -32% | -$613K | 0.1% | 138 |
|
|
2023
Q3 | $1.89M | Buy |
35,798
+11
| +0% | +$577 | 0.14% | 133 |
|
|
2023
Q2 | $1.94M | Sell |
35,787
-38
| -0.1% | -$1.99K | 0.13% | 139 |
|
|
2023
Q1 | $1.79M | Buy |
35,825
+2,263
| +7% | +$107K | 0.12% | 152 |
|
|
2022
Q4 | $1.55M | Buy |
33,562
+3,386
| +11% | +$147K | 0.12% | 149 |
|
|
2022
Q3 | $1.17M | Sell |
30,176
-17,491
| -37% | -$702K | 0.09% | 166 |
|
|
2022
Q2 | $1.78M | Sell |
47,667
-4
| -0% | -$163 | 0.12% | 154 |
|
|
2022
Q1 | $2.11M | Sell |
47,671
-23,381
| -33% | -$1.01M | 0.1% | 160 |
|
|
2021
Q4 | $3.02M | Sell |
71,052
-8,643
| -11% | -$363K | 0.13% | 148 |
|
|
2021
Q3 | $3.46M | Buy |
79,695
+8
| +0% | +$354 | 0.16% | 140 |
|
|
2021
Q2 | $3.41M | Buy |
79,687
+7,711
| +11% | +$324K | 0.15% | 161 |
|
|
2021
Q1 | $2.78M | Sell |
71,976
-57,898
| -45% | -$2.19M | 0.13% | 177 |
|
|
2020
Q4 | $4.67M | Buy |
129,874
+74,408
| +134% | +$2.68M | 0.28% | 108 |
|
|
2020
Q3 | $2.12M | Buy |
55,466
+144
| +0.3% | +$5.55K | 0.13% | 201 |
|
|
2020
Q2 | $1.93M | Sell |
55,322
-5,681
| -9% | -$205K | 0.12% | 203 |
|
|
2020
Q1 | $1.99M | Sell |
61,003
-21,494
| -26% | -$840K | 0.14% | 190 |
|
|
2019
Q4 | $3.73M | Buy |
82,497
+68,152
| +475% | +$2.85M | 0.18% | 151 |
|
|
2019
Q3 | $584K | Buy |
+14,345
| New | +$608K | 0.03% | 537 |
|
|
2019
Q2 | – | Sell |
-10,225
| Closed | -$393K | – | 865 |
|
|
2019
Q1 | $393K | Sell |
10,225
-2,464
| -19% | -$94.1K | 0.02% | 678 |
|
|
2018
Q4 | $448K | Buy |
12,689
+5,359
| +73% | +$194K | 0.02% | 560 |
|
|
2018
Q3 | $282K | Buy |
+7,330
| New | +$256K | 0.01% | 802 |
|
|
2017
Q4 | – | Sell |
-4,102
| Closed | -$120K | – | 850 |
|
|
2017
Q3 | $120K | Sell |
4,102
-54,627
| -93% | -$1.51M | 0.01% | 496 |
|
|
2017
Q2 | $1.63M | Sell |
58,729
-20,511
| -26% | -$544K | 0.02% | 544 |
|
|
2017
Q1 | $1.97M | Sell |
79,240
-122,001
| -61% | -$2.97M | 0.03% | 507 |
|
|
2016
Q4 | $4.35M | Sell |
201,241
-728
| -0.4% | -$15.9K | 0.08% | 293 |
|
|
2016
Q3 | $4.81M | Sell |
201,969
-20,062
| -9% | -$479K | 0.08% | 271 |
|
|
2016
Q2 | $5.19M | Sell |
222,031
-14,112
| -6% | -$305K | 0.08% | 285 |
|
|
2016
Q1 | $4.44M | Sell |
236,143
-33,091
| -12% | -$581K | 0.07% | 291 |
|
|
2015
Q4 | $4.96M | Buy |
269,234
+12,210
| +5% | +$219K | 0.08% | 275 |
|
|
2015
Q3 | $4.22M | Sell |
257,024
-1,868
| -0.7% | -$31.9K | 0.07% | 289 |
|
|
2015
Q2 | $4.58M | Buy |
258,892
+34,066
| +15% | +$609K | 0.07% | 307 |
|
|
2015
Q1 | $3.99M | Sell |
224,826
-3,067
| -1% | -$48.5K | 0.06% | 331 |
|
|
2014
Q4 | $3.02M | Sell |
227,893
-2,160
| -0.9% | -$27.6K | 0.05% | 398 |
|
|
2014
Q3 | $2.72M | Buy |
230,053
+52
| +0% | +$655 | 0.04% | 419 |
|
|
2014
Q2 | $2.94M | Hold |
230,001
| – | – | 0.04% | 396 |
|
|
2014
Q1 | $3.11M | Sell |
230,001
-143,734
| -38% | -$1.89M | 0.05% | 382 |
|
|
2013
Q4 | $4.49M | Sell |
373,735
-53,108
| -12% | -$627K | 0.08% | 279 |
|
|
2013
Q3 | $5.01M | Sell |
426,843
-876,318
| -67% | -$9.48M | 0.09% | 254 |
|
|
2013
Q2 | $12.1M | Buy |
+1,303,161
| New | +$11.1M | 0.26% | 107 |
|
Other funds holding BSX
GAM Holding's BSX Position: Q4 2025 in Review
GAM Holding reduced its Boston Scientific (BSX) stake by 15% in Q4 2025, selling an estimated $386K and leaving 22,849 shares worth $2.18M. The position accounts for 0.14% of the portfolio, ranked #147.
GAM Holding first reported a position in BSX in Q2 2013 and has held it in 47 quarters since. The position peaked at $12.1M in Q2 2013. 1,784 funds tracked by Wall St. Rank hold BSX as of Q4 2025.
- GAM Holding held 22,849 shares of Boston Scientific worth $2.18M as of Q4 2025.
- GAM Holding sold 3,935 Boston Scientific shares in Q4 2025, an estimated $386K.
- Boston Scientific made up 0.14% of GAM Holding's portfolio in Q4 2025, its #147 holding.
- GAM Holding first reported a position in Boston Scientific in Q2 2013 and has held it in 47 quarters since.
- GAM Holding's Boston Scientific position peaked at $12.1M in Q2 2013.
- 1,784 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.
Based on GAM Holding's 13F filing for Q4 2025, filed 17 Feb 2026.